Napa Wealth Management Makes New $267,000 Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

Napa Wealth Management bought a new position in Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 449 shares of the biotechnology company’s stock, valued at approximately $267,000.

Several other hedge funds and other institutional investors have also bought and sold shares of AXON. Asset Dedication LLC lifted its position in Axon Enterprise by 11.3% in the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after purchasing an additional 18 shares during the last quarter. Bleakley Financial Group LLC lifted its position in Axon Enterprise by 1.3% in the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock valued at $908,000 after purchasing an additional 20 shares during the last quarter. Venturi Wealth Management LLC lifted its position in Axon Enterprise by 2.7% in the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock valued at $477,000 after purchasing an additional 21 shares during the last quarter. Beacon Pointe Advisors LLC lifted its position in Axon Enterprise by 2.6% in the fourth quarter. Beacon Pointe Advisors LLC now owns 864 shares of the biotechnology company’s stock valued at $513,000 after purchasing an additional 22 shares during the last quarter. Finally, Burns Matteson Capital Management LLC lifted its position in Axon Enterprise by 3.4% in the fourth quarter. Burns Matteson Capital Management LLC now owns 757 shares of the biotechnology company’s stock valued at $450,000 after purchasing an additional 25 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling

In other news, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction on Monday, April 21st. The stock was sold at an average price of $540.99, for a total value of $5,409,900.00. Following the sale, the chief executive officer now directly owns 3,063,982 shares of the company’s stock, valued at approximately $1,657,583,622.18. This represents a 0.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Jeri Williams sold 307 shares of the stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the sale, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. This represents a 15.87% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 19,964 shares of company stock valued at $12,189,275 over the last ninety days. Company insiders own 4.40% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have weighed in on AXON. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Barclays boosted their price objective on Axon Enterprise from $726.00 to $735.00 and gave the company an “overweight” rating in a research report on Friday, May 9th. JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. Finally, Needham & Company LLC upped their target price on Axon Enterprise from $600.00 to $750.00 and gave the company a “buy” rating in a report on Thursday, May 8th. One analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $640.91.

Axon Enterprise Price Performance

Shares of AXON stock opened at $724.77 on Wednesday. The stock has a market cap of $56.42 billion, a price-to-earnings ratio of 187.28, a PEG ratio of 5.17 and a beta of 1.24. The business’s fifty day moving average is $572.18 and its 200 day moving average is $588.52. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $732.17. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.07. The company had revenue of $603.63 million for the quarter, compared to analysts’ expectations of $585.67 million. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The firm’s revenue for the quarter was up 31.3% on a year-over-year basis. During the same period in the prior year, the firm earned $1.15 earnings per share. Research analysts expect that Axon Enterprise, Inc. will post 5.8 EPS for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.